Selio Medical was cofounded by BioInnovate fellows from 2014/2015 Colm MCGarvey and Garret Ryan to create a novel lung biopsy needle to prevent pneumothorax. Following support from Enterprise Ireland, the company was accepted in 2017 to the prestigious Medtech Innovator Accelerator in San Francisco where the team placed third out of 600 entries. Selio Medical has won numerous awards to date and is close to closing a €2.5million Series A funding round which will provide impetus towards commercialisation of the company’s novel solution.
- Established: 2016
- Funding: €515,000
- Status: Towards Commercialisation